Rapid UTI PCR testing entered UK clinical use for the first time at the Royal Hospital Chelsea on October 28, 2026.

TOKYO, Oct. 28, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.06 billion (USD 6.8 million 1) in nine R&D projects ...

A rapid PCR system detected the PCNSL-specific MYD88 L265P mutation in tumor tissue and cerebrospinal fluid, achieving 100% ...

A new real-time fluorescent recombinase-aided amplification assay detects the optrA resistance gene in Enterococcaceae within ...

The Allahabad High Court has ruled that the absence of an RT-PCR report cannot justify rejecting a claim for Rs 50 lakh in ex ...

Veterinarians in Latvia have documented three cases of feline histoplasmosis in a region where the disease had never before ...

Negros Occidental hog raisers may see farmgate prices improve if the province gains access to additional markets, ...

LAPU-LAPU CITY, Cebu — Cebu has tightened documentary and quarantine requirements for shipments of live hogs, pork, and pork ...

Medical and consumer genetics innovator Genefluence today announces the first use of its rapid, near-patient diagnostic platform to screen for urinary tract infections (UTIs), at the Royal Hospital ...

Portable, cartridge-based multiplex systems, digital integration, and expansion into oncology and remote care drive point-of-care molecular diagnostics adoption.Dublin, Oct. (GLOBE NEWSWIRE) -- "Point ...

Roche announced the global launch of the VENTANA BAP1 (SP527) test. This automated, ready-to-use immunohistochemistry (IHC) assay provides a reliable, highly specific diagnostic tool to help ...

Clearance And CLIA Waiver From The FDA For The BIOFIRE SPOTFIRE Vaginitis Panel CI Oct. 19 BioMérieux Obtains Emergency Use Listing from World Health Organization for Biofire MT Sep. 24 BioMérieux ...